一次抗体と二次抗体-抗-エピトープタグ、免疫測定、Cas 9 » Primary Antibodies » 抗イディオタイプ抗体製品 » Anti-Rituximab Antibody (6C1), mAb, Mouse
Anti-Rituximab Antibody (6C1), MAb, Mouse

ELISA binding of Anti-Rituximab Antibody (6C1) (GenScript, A01969-40) with Rituximab. While the antibody does not recognize the human IgG (data not shown).Coating antigen: Rituximab, 1 µg/ml.
Anti-Rituximab Antibody (6C1) (GenScript, A01969-40) dilutions start from 2,000 ng/ml.
EC₅₀= 7.819 ng/ml.

Anti-Rituximab Antibody (6C1), MAb, Mouse

Standard curve of Rituximab Sandwich ELISA. The Rituximab Sandwich ELISA assay is developed by using Anti-Rituximab Antibody (6C1), mAb, Mouse (GenScript, A01969-40) and Anti-Rituximab Antibody (17B6), mAb, Mouse (GenScript, A01970-40) as the capture and detection antibodies, respectively.
In this ELISA assay, Anti-Rituximab Antibody (17B6), mAb, Mouse (GenScript, A01970-40) was labeled with Biotin. GenScript can provide customized conjugation services for this product per customer's request.
The sensitivity is less than 1 ng/ml.

Anti-Rituximab Antibody (6C1), mAb, Mouse

The product is specific for Rituximab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01970-40, Anti-Rituximab Antibody (17B6), mAb, Mouse.
A01969
¥25,548.00

Ask us a question
Overview
Specificity The product is specific for Rituximab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01970-40, Anti-Rituximab Antibody (17B6), mAb, Mouse.
Host Species Mouse
Immunogen Rituximab
Conjugate Unconjugated

Applications
Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
ELISA 0.01-0.1 µg/ml

Properties
Form Lyophilized
Storage Buffer lyophilized with PBS, pH 7.4, containing 0.02% sodium azide.
Reconstitution Reconstitute the lyophilized powder with deionized water (or equivalent) to an final concentration of 0.5 mg/mL.
Storage Instructions The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid repeated freezing and thawing cycles.
Purification Protein A affinity column
Isotype Mouse IgG1
Clonality Monoclonal
Clone ID 6C1
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

Examples
  • Anti-Rituximab Antibody (6C1), MAb, Mouse
    • Anti-Rituximab Antibody (6C1), MAb, Mouse

    ELISA binding of Anti-Rituximab Antibody (6C1) (GenScript, A01969-40) with Rituximab. While the antibody does not recognize the human IgG (data not shown).Coating antigen: Rituximab, 1 µg/ml.
    Anti-Rituximab Antibody (6C1) (GenScript, A01969-40) dilutions start from 2,000 ng/ml.
    EC₅₀= 7.819 ng/ml.

  • Anti-Rituximab Antibody (6C1), MAb, Mouse
    • Anti-Rituximab Antibody (6C1), MAb, Mouse

    Standard curve of Rituximab Sandwich ELISA. The Rituximab Sandwich ELISA assay is developed by using Anti-Rituximab Antibody (6C1), mAb, Mouse (GenScript, A01969-40) and Anti-Rituximab Antibody (17B6), mAb, Mouse (GenScript, A01970-40) as the capture and detection antibodies, respectively.
    In this ELISA assay, Anti-Rituximab Antibody (17B6), mAb, Mouse (GenScript, A01970-40) was labeled with Biotin. GenScript can provide customized conjugation services for this product per customer's request.
    The sensitivity is less than 1 ng/ml.


Background
Target Background Rituximab (Rituxan) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of hematological cancers and autoimmune diseases. When Rituximab binds to CD20 on the surface of normal and malignant B cells, natural killer (NK) cells is activated to destroy these B cells. It is therefore used to treat diseases with too many B cells, overactive B cells, or dysfunctional B cells. Anti-Rituximab Antibody (6C1), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Rituximab.
Synonyms Mouse monoclonal to Rituxan

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.